The complexes [Pt(en)MeCO-Met-S)Cl]NO31, [Pt(en)(MeCO-Met-S)2][NO3]22(en = ethane-1,2-diamine, MeCO-Met =N-acetyl-L-methionine) and their 15N analogues (1n and 2n) have been prepared and characterized by 1H, 13C and two-dimensional [1H, 15N] spectroscopy. Complex 1(half-life 3.9 h at 310 K) hydrolysed more slowly than [Pt(en)Cl2], whereas 2 was stable in water. The reaction of 1n with guanosine 5′-monophosphate (5′-GMP) gave a stable mixed-ligand complex [Pt([15N]en){MeCO-Met(1–)-S}(5′-GMP-N7)]+, and the reaction with guanylyl(3′-5′)guanosine (GpG) gave two different monofunctional adducts [Pt([15N]en){MeCO-Met(1–)-S}(GpG-N7)]+, due to platination of either 3′- or 5′-G, with a preferential formation of one over the other (ratio 60:40). During the initial stages of the reaction the chelated complex [Pt([15N]en){MeCO-Met(2–)-S,N}]3 was also observed, which subsequently reacted with 5′-GMP or GpG via ring opening to give monofunctional adducts. Reactions of complex 2 with 5′-GMP and GpG also lead to such adducts, with release of MeCO-Met. Little conversion of monofunctional adducts into bifunctional adducts was observed. Methionine and its derivatives could play a role in the trapping of monofunctional adducts of platinum anticancer drugs with DNA in vivo.
No takes yet. Share an insight, caveat, or question.
Barnham et al. (1996) studied this question.